文献速递关节外科

高危患者延长口服抗生素预防可大幅降低初次全髋与全膝关节置换术后90天感染率

Extended Oral Antibiotic Prophylaxis in High-Risk Patients Substantially Reduces Primary Total Hip and Knee Arthroplasty 90-Day Infection Rate.
PubMed 文献 · J Bone Joint Surg Am · 2018-01-01

该回顾性队列研究纳入2011至2016年在一所郊区学术医院完成的2181例初次全膝与全髋关节置换术,自2015年1月起对感染高危患者出院后延长口服抗生素预防7天。高危患者未接受延长预防者术后90天发生假体周围关节感染的风险在全膝置换为接受者的4.9倍(p=0.009)、全髋置换为4.0倍(p=0.037)。作者认为该措施带来有统计学与临床意义的感染率下降,但鼓励在采纳前进一步研究与权衡。

要点

  • 高危患者未接受延长口服抗生素预防者,全膝置换后90天假体周围关节感染风险为接受者的4.9倍(p=0.009)。
  • 高危患者未接受延长口服抗生素预防者,全髋置换后90天假体周围关节感染风险为接受者的4.0倍(p=0.037)。
  • 全膝与全髋置换术后90天感染率分别为1.0%与2.2%,作者鼓励在采纳延长预防方案前进一步研究并权衡耐药风险。

核心结论

  • 延长术后抗生素预防使所选感染高危患者90天感染率出现有统计学意义且有临床意义的下降。
  • 作者鼓励在采纳高危关节置换术后延长口服抗生素预防方案前进一步研究与审议,并将获益与抗菌药物耐药增加等潜在不良后果适当权衡。

研究设计与样本

  • 回顾性队列研究,纳入2011年至2016年在一所郊区学术医院完成的2181例初次全膝关节置换术与初次全髋关节置换术,采用现代围手术期与感染预防方案。
  • 自2015年1月起对假体周围关节感染高危患者实施出院后延长口服抗生素预防7天。
  • 比较接受与未接受延长口服抗生素预防两组中90天内诊断为假体周围关节感染的患者百分比,p≤0.05为显著。
  • 证据等级:治疗性III级。

主要发现

  • 全膝关节置换术后90天感染率为1.0%,全髋关节置换术后90天感染率为2.2%。
  • 未接受延长抗生素预防的高危患者在全膝置换后发生假体周围关节感染的可能性是接受延长预防高危患者的4.9倍(p=0.009)。
  • 未接受延长抗生素预防的高危患者在全髋置换后发生假体周围关节感染的可能性是接受延长预防高危患者的4.0倍(p=0.037)。

临床怎么用

  • 作者鼓励在采纳高危关节置换术后延长口服抗生素预防方案前进一步研究与审议,并将获益与抗菌药物耐药增加等潜在不良后果适当权衡。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Total joint arthroplasty (TJA) episodic payment models shift risk and cost of periprosthetic joint infection (PJI) to surgeons and hospitals, causing some to avoid treating high-risk patients. Furthermore, there are little data to support optimization of host factors preoperatively to decrease PJI, and recent literature supports using extended antibiotic prophylaxis following reimplantation TJA. The purpose of this study was to evaluate whether extended oral antibiotic prophylaxis minimized PJI after primary TJA in high-risk patients. METHODS: A retrospective cohort study was performed of 2,181 primary total knee arthroplasties (TKAs) and primary total hip arthroplasties (THAs) carried out from 2011 through 2016 at a suburban academic hospital with modern perioperative and infection-prevention protocols. Beginning in January 2015, extended oral antibiotic prophylaxis for 7 days after discharge was implemented for patients at high risk for PJI. The percentages of patients diagnosed with PJI within 90 days were identified and compared between groups that did and did not receive extended oral antibiotic prophylaxis, with p ≤ 0.05 indicating significance. RESULTS: The 90-day infection rates were 1.0% and 2.2% after the TKAs and THAs, respectively. High-risk patients without extended antibiotic prophylaxis were 4.9 (p = 0.009) and 4.0 (p = 0.037) times more likely to develop PJI after TKA and THA, respectively, than high-risk patients with extended antibiotic prophylaxis. CONCLUSIONS: Extended postoperative antibiotic prophylaxis led to a statistically significant and clinically meaningful reduction in the 90-day infection rate of selected patients at high risk for infection. We encourage further study and deliberation prior to adoption of a protocol involving extended oral antibiotic prophylaxis after high-risk TJA, with the benefits weighed appropriately against potential adverse consequences such as increasing the development of antimicrobial resistance. LEVEL OF EVIDENCE: Therapeutic Level III. See Instructions for Authors for a complete description of levels of evidence.

来源:J Bone Joint Surg Am,查看原文。版权归原作者所有。

引用

  1. Inabathula A, Dilley JE, Ziemba-Davis M, et al. Extended Oral Antibiotic Prophylaxis in High-Risk Patients Substantially Reduces Primary Total Hip and Knee Arthroplasty 90-Day Infection Rate. J Bone Joint Surg Am. 2018. PMID: 30562290. doi:10.2106/JBJS.17.01485

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。